Companies
Discover all trending biotech companies
Discover all trending biotech companies
Company Research Platform
Annual Revenue
$ 33
Global Employees
12,800
Patents Filed
29
This segment focuses on the research, development, manufacturing, and commercialization of prescription drugs. Kalbe Farma's R&D efforts in this area include developing generic, branded, and licensed drugs targeting various therapeutic areas. The company conducts clinical trials to ensure the safety and efficacy of its pharmaceutical products. Key therapeutic areas include neurology, cardiology, and infectious diseases. The segment aims to improve patient outcomes by providing high-quality, affordable medications to hospitals, pharmacies, and drug stores. Kalbe Farma leverages its strong distribution network to ensure market access and maintain a competitive edge. Future opportunities include expanding its portfolio of innovative medicines and exploring strategic partnerships to enhance its R&D capabilities. Regulatory compliance and adherence to international quality standards are critical aspects of this segment.
The Consumer Health segment encompasses the development, manufacturing, and marketing of over-the-counter (OTC) drugs, energy drinks, ready-to-drink products, supplements, and other preventive healthcare products. Kalbe Farma invests in R&D to create innovative consumer health products that address various health needs and preferences. This segment leverages consumer insights and market trends to develop products that resonate with a broad audience. Key product categories include vitamins, minerals, and supplements (VMS), cough and cold remedies, and pain relievers. The segment focuses on improving consumer well-being by providing accessible and affordable healthcare solutions. Kalbe Farma utilizes various marketing channels, including digital platforms and retail partnerships, to reach consumers effectively. Future opportunities include expanding its portfolio of natural and organic products and leveraging digital technologies to personalize consumer health experiences. Regulatory compliance and adherence to advertising standards are essential aspects of this segment.
This segment is dedicated to the development, manufacturing, and marketing of nutritional products for infants, toddlers, children, pre-teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. Kalbe Farma's R&D efforts in this area focus on creating scientifically formulated nutritional products that meet specific dietary requirements. The company conducts clinical studies to validate the health benefits of its nutritional products. Key product categories include infant formula, follow-on formula, growing-up milk, and adult nutritional supplements. The segment aims to improve health outcomes by providing high-quality, evidence-based nutritional solutions. Kalbe Farma collaborates with healthcare professionals and nutrition experts to promote the importance of proper nutrition. Future opportunities include expanding its portfolio of specialized nutritional products and leveraging digital technologies to provide personalized nutrition advice. Regulatory compliance and adherence to food safety standards are critical aspects of this segment.
The Distribution and Logistics segment manages the distribution of Kalbe Farma's products and provides logistics services to other healthcare companies. Kalbe Farma invests in advanced supply chain technologies and infrastructure to ensure efficient and reliable distribution. This segment leverages data analytics to optimize inventory management and improve delivery times. Key services include warehousing, transportation, and order fulfillment. The segment aims to improve healthcare access by ensuring that pharmaceutical and nutritional products are available to patients and consumers across Indonesia. Kalbe Farma collaborates with logistics partners to expand its distribution network and enhance its service capabilities. Future opportunities include leveraging digital technologies to provide real-time tracking and visibility and expanding its logistics services to other healthcare companies. Regulatory compliance and adherence to transportation safety standards are essential aspects of this segment.